Arbutus Biopharma Corporation is a publicly traded Canadian (NASDAQ: ABUS) biopharmaceutical company with an expertise in liposomal drug delivery and...

Biopharma, a position he maintained at Tekmira Pharmaceuticals when the two companies merged in March 2015. He also was chair of the board of Arbutus...

patent by Arbutus Biopharma in connection with the dispute. In April 2024, however, the court issued an order that strengthened Arbutus's arguments by...

of howitzer created by the Ottoman Empire Abus Valley, Antarctica Arbutus Biopharma, American biopharmaceutical company (NASDAQ stock symbol ABUS) Mount...

Arbutus Biopharma. Archived from the original on 2022-10-03. Retrieved 2022-10-03. "Acuitas Therapeutics Inc. v. Genevant Sciences GMBH, and Arbutus Biopharma...

currently the Chief Scientific Officer and co-founder of Arbutus Biopharma, formerly as OnCore Biopharma prior to its 2015 merger with Tekmira Pharmaceuticals...

mRNA-1273 has been the subject of ongoing patent litigation with Arbutus Biopharma, from whom Moderna had previously licensed LNP technology. On 4 September...

experimental antiviral drug for Ebola disease that was developed by Arbutus Biopharma (formerly Tekmira Pharmaceuticals Corp.) in Vancouver, Canada. The...

a truce, issue joint statement". mint. Retrieved 26 April 2023. "Arbutus Biopharma Corp. v. Moderna, Inc., Civil Action 22-252 | Casetext Search + Citator"...

DNA and gene editing tools such as CRISPR. Other companies, such as Arbutus Biopharma and Arcturus Therapeutics, offer non-viral, non-cell-targeted approaches...